Literature DB >> 2647103

Obesity, metabolism, and the sympathetic nervous system.

L Landsberg1, D R Krieger.   

Abstract

The association of hypertension and obesity is poorly understood. Studies conducted in our laboratory over the last decade, in conjunction with recent clinical and epidemiological observations, suggest that hypertension in the obese is derived from a fundamental relationship between dietary intake and sympathetic nervous system (SNS) activity. The application of kinetic techniques to the measurement of norepinephrine (NE) turnover rate in sympathetically innervated tissues of laboratory rodents has defined a relationship between the SNS and dietary intake. Fasting or caloric restriction suppresses sympathetic activity in a variety of organs of the rat, including heart and interscapular brown adipose tissue. Overfeeding a mixed, palatable, "cafeteria" diet stimulates sympathetic activity in these same tissues. The stimulatory effect of mixed diets is due to the carbohydrate and fat content, because these two latter nutrients stimulate sympathetic activity even when total caloric intake is not increased. Insulin-mediated glucose metabolism within central neurons associated with the ventromedial hypothalamus (VMH) plays an important role in the relationship between dietary intake and SNS activity as indicated by the following observations: (1) Hypoglycemia (noninsulin-mediated) is associated with suppression of the SNS (despite concomitant adrenal medullary stimulation); (2) 2-deoxyglucose, an intracellular inhibitor of glucose metabolism, decreases sympathetic activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2647103     DOI: 10.1093/ajh/2.3.125s

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  28 in total

Review 1.  The medical risks of obesity.

Authors:  F Xavier Pi-Sunyer
Journal:  Obes Surg       Date:  2002-04       Impact factor: 4.129

2.  Adipocyte dysfunction and hypertension.

Authors:  Junlan Zhou; Gangjian Qin
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

3.  Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.

Authors:  E A Anderson; R P Hoffman; T W Balon; C A Sinkey; A L Mark
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 4.  Low-carbohydrate diets cause obesity, low-carbohydrate diets reverse obesity: a metabolic mechanism resolving the paradox.

Authors:  Charles V Mobbs; Jason Mastaitis; Kelvin Yen; Joseph Schwartz; Vinuta Mohan; Michal Poplawski; Fumiko Isoda
Journal:  Appetite       Date:  2006-12-01       Impact factor: 3.868

5.  The clinical biochemistry of obesity.

Authors:  Ken A Sikaris
Journal:  Clin Biochem Rev       Date:  2004-08

6.  Different pathomechanisms of essential and obesity-associated hypertension in adolescents.

Authors:  Akos Baráth; Sándor Túri; Ilona Németh; Csaba Bereczki; Balázs Gellén; Ibolya Haszon; Péter Monostori
Journal:  Pediatr Nephrol       Date:  2006-08-08       Impact factor: 3.714

7.  Contributors to Metabolic Disease Risk Following Spinal Cord Injury.

Authors:  Daniel L Smith; Ceren Yarar-Fisher
Journal:  Curr Phys Med Rehabil Rep       Date:  2016-07-06

8.  Factors associated with obesity in Kuwaiti children.

Authors:  M A Moussa; A A Shaltout; D Nkansa-Dwamena; M Mourad; N Alsheikh; N Agha; D O Galal
Journal:  Eur J Epidemiol       Date:  1999-01       Impact factor: 8.082

Review 9.  Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.

Authors:  Alexandre A da Silva; Jussara M do Carmo; Xuan Li; Zhen Wang; Alan J Mouton; John E Hall
Journal:  Can J Cardiol       Date:  2020-02-12       Impact factor: 5.223

10.  Pathophysiological role of leptin in obesity-related hypertension.

Authors:  M Aizawa-Abe; Y Ogawa; H Masuzaki; K Ebihara; N Satoh; H Iwai; N Matsuoka; T Hayashi; K Hosoda; G Inoue; Y Yoshimasa; K Nakao
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.